The long-lasting effects of JDTic, a kappa opioid receptor antagonist, on the expression of ethanol-seeking behavior and the relapse drinking of female alcohol-preferring (P) rats

Pharmacology Biochemistry and Behavior

Volumn 101, Issue 4, 2012, Pages 581-587

  Deehan Jr , Gerald A ^a   McKinzie, David L ^b   Carroll, F Ivy ^c   McBride, William J ^a   Rodd, Zachary A ^a  

^a INDIANA UNIVERSITY   (United States)

^b ELI LILLY AND COMPANY   (United States)

^c RTI INTERNATIONAL   (United States)

Author keywords

Ethanol relapse; Ethanol self administration; Ethanol seeking; JDTic; Kappa opioid receptor; Pavlovian Spontaneous Recovery

Indexed keywords

JDTIC; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

ALCOHOL SEEKING BEHAVIOR; ALCOHOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRINKING BEHAVIOR; DRUG EFFECT; DRUG MECHANISM; EXPERIMENTAL TEST; FEMALE; MAINTENANCE THERAPY; NONHUMAN; PAVLOVIAN SPONTANEOUS RECOVERY; PRIORITY JOURNAL; RAT; RELAPSE;

ALCOHOL DRINKING; ALCOHOLISM; ANIMALS; BEHAVIOR, ADDICTIVE; CONDITIONING, OPERANT; DRUG-SEEKING BEHAVIOR; ETHANOL; FEMALE; PIPERIDINES; RATS; RECEPTORS, OPIOID, KAPPA; RECURRENCE; REINFORCEMENT (PSYCHOLOGY); SELF ADMINISTRATION; TETRAHYDROISOQUINOLINES;

ANIMALIA; RATTUS;

EID: 84859073865     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2012.03.006     Document Type: Article

References (72)

1. R.F. Anton, S.S. O'Malley, D.A. Ciraulo, R.A. Cisler, D. Couper, and D.M. Donovan Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial JAMA 295 2006 2003 2017
2. N.E. Badia-Elder, A.K. Mosemiller, R.L. Elder, and J.C. Froehlich Naloxone retards the expression of a genetic predisposition toward alcohol drinking Psychopharmacology (Berl) 144 1999 205 212
3. P.M. Beardsley, J.L. Howard, K.L. Shelton, and F.I. Carroll Differential effects of the novel kappa opioid receptor antagonist, JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats Psychopharmacology (Berl) 183 2005 118 126
4. P.M. Beardsley, G.T. Pollard, J.L. Howard, and F.I. Carroll Effectiveness of analogs of the kappa opioid receptor antagonist (3R)-7-Hydroxy-N-((1S)-1- {[(3R,4R)-4-(3-hydroxyphenyl)-3,4dimethyl-1-piperidinyl]methyl}-2-methylpropyl) -1,2,3,4-tetrahydro-3-insquinoliecarboxamide (JDTic) to reduce U50,488-induced diuresis and stree-induced cocaine reinstatement in rats Psychopharmacology (Berl) 210 2010 189 198
5. I. Carroll, J.B. Thomas, L.A. Dykstra, A.L. Granger, R.M. Allen, and J.L. Howard Pharmacological properties of JDTic: a novel kappa-opioid receptor antagonist Eur J Pharmacol 501 2004 111 119
6. F.I. Carroll, L.S. Harris, and M.D. Aceto Effects of JDTic, a selective kappa-opioid receptor antagonist, on the development and expression of physical dependence on morphine using a rat continuous-infusion model Eur J Pharmacol 524 2005 89 94
7. C. Contet, B.L. Kieffer, and K. Befort Mu opioid receptor: a gateway to drug addiction Curr Opin Neurobiol 14 2004 370 378
8. D. Davidson, R. Swift, and E. Fitz Naltrexone increases the latency to drink alcohol in social drinkers Alcohol Clin Exp Res 20 1996 732 739
9. D.P. Devine, and R.A. Wise Self-administration of morphine, DAMGO, and DPDPE into the ventral tegmental area of rats J Neurosci 14 1994 1978 1984
10. R. Dhaher, S.R. Hauser, B. Getachew, R.L. Bell, W.J. McBride, and D.L. McKinzie The Orexin-1 Receptor Antagonist SB-334867 Reduces Alcohol Relapse Drinking, but not Alcohol-Seeking, in Alcohol-Preferring (P) Rats J Addict Med 4 2010 153 159
11. G. Di Chiara, and A. Imperato Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats J Pharmacol Exp Ther 244 1988 1067 1080
12. G. Di Chiara, E. Acquas, and G. Tanda Ethanol as a neurochemical surrogate of conventional reinforcers: the dopamine-opioid link Alcohol 13 1996 13 17
13. M. Domjan, and B. Burkhard The principles of learning and behavior 1982 Brooks Cole Publishing Monterey, CA
14. B.A. Donzanti, J.S. Althaus, M.M. Payson, and P.F. Von Voigtlander Kappa agonist-induced reduction in dopamine release: site of action and tolerance Res Commun Chem Pathol Pharmacol 78 1992 193 210
15. W.M. Doyon, E.C. Howard, T.S. Shippenberg, and R.A. Gonzales Kappa-opioid receptor modulation of accumbal dopamine concentration during operant ethanol self-administration Neuropharmacology 51 2006 487 496
16. P. Fadda, S. Tronci, G. Colombo, and W. Fratta Differences in the opioid system in selected brain regions of alcohol-preferring and alcohol-nonpreferring rats Alcohol Clin Exp Res 23 1999 1296 1305
17. C.K. Farren, and S. McElroy Predictive factors for relapse after an integrated inpatient treatment programme for unipolar depressed and bipolar alcoholics Alcohol Alcohol 45 2010 527 533
18. J.C. Froehlich, J. Harts, L. Lumeng, and T.K. Li Naloxone attenuates voluntary ethanol intake in rats selectively bred for high ethanol preference Pharmacol Biochem Behav 35 1990 385 390
19. G. Gerra, A. Fantoma, and A. Zaimovic Naltrexone and buprenorphine combination in the treatment of opioid dependence J Psychopharmaocol 20 2006 806 814
20. C. Gianoulakis Influence of the endogenous opioid system on high alcohol consumption and genetic predisposition to alcoholism J Psychiatry Neurosci 26 2001 304 318
21. B. Getachew, S.R. Hauser, R. Dhaher, S.N. Katner, R.L. Bell, S.M. Oster, W.J. McBride, and Z.A. Rodd CB1 receptors regulate alcohol-seeking behavior and alcohol self-administration of alcohol-preferring (P) rats Pharmacol Biochem Behav 97 2011 669 675
22. R. Gueorguieva, R. Wu, D. Donovan, B.J. Rounsaville, D. Couper, and J.H. Krystal Naltrexone and combined behavioral intervention effects on trajectories of drinking in the COMBINE study Drug Alcohol Depend 107 2010 221 229
23. A. Heinz, A. Beck, S.M. Grusser, A.A. Grace, and J. Wrase Identifying the neural circuitry of alcohol craving and relapse vulnerability Addict Biol 14 2009 108 118
24. G.O. Hjelmstad, and H.L. Fields Kappa opioid receptor inhibition of glutamatergic transmission in the nucleus accumbens shell J Neurophysiol 85 2001 1153 1158
25. Institute of Laboratory Animal Resources Guide for the Care and Use of Laboratory Animals 7th ed. 1996 National Academy Press Washington D.C.
26. K.J. Jackson, F.I. Carroll, S.S. Negus, and M.I. Damaj Effect of the selective kappa-opioid receptor antagonist JDTic on nicotine antinociception, reward, and withdrawal in the mouse Psychopharmacology (Berl) 210 2010 285 294
27. B.A. Johnson, and N. Ait-Daoud Neuropharmacological treatments for alcoholism: scientific basis and clinical findings Psychopharmacology (Berl) 149 2000 327 344
28. S.W. Johnson, and R.A. North Opioids excite dopamine neurons by hyperpolarization of local interneurons J Neurosci 12 1992 483 488
29. H.L. June, C. Grey, C. Warren-Reese, L.F. Durr, A. Ricks-Cords, and A. Johnson The opioid receptor antagonist nalmefene reduces responding maintained by ethanol presentation: preclinical studies in ethanol-preferring and outbred Wistar rats Alcohol Clin Exp Res 22 1998 2174 2185
30. H.L. June, R. Cummings, W.J. Eiler, K.L. Foster, P.F. McKay, and R. Seyoum Central opioid receptors differentially regulate the nalmefene-induced suppression of ethanol- and saccharin-reinforced behaviors in alcohol-preferring (P) rats Neuropsychopharmacology 29 2004 285 299
31. T.E. Kippin, R.A. Fuchs, R.H. Mehta, J.M. Case, M.P. Parker, and H.A. Bimonte-Nelson See RE Potentiation of cocaine-primed reinstatement of drug seeking in female rats during estrus Psychopharmacology (Berl) 182 2005 245 252
32. A.T. Knoll, and W.A. Carlezon Jr. Dynorphin, stress, and depression Brain Res 1314 2010 56 73
33. A.T. Knoll, E.G. Meloni, J.B. Thomas, F.I. Carroll, and W.A. Carlezon Jr. Anxiolytic-like effects of kappa-opioid receptor antagonists in models of unlearned and learned fear in rats J Pharmacol Exp Ther 323 2007 838 845
34. G.F. Koob, A.J. Roberts, B.L. Kieffer, C.J. Heyser, S.N. Katner, and R. Ciccocioppo Animal models of motivation for drinking in rodents with a focus on opioid receptor neuropharmacology Recent Dev Alcohol 16 2003 263 281
35. S. Lindholm, K. Ploj, J. Frank, and I. Nylander Repeated ethanol administration induces short- and long-term changes in enkephalin and dynorphin tissue concentration in rat brain Alcohol 22 2000 165 171
36. S. Lindholm, A. Rosin, I. Dahlin, J. Georgieva, and J. Franck Ethanol alters the effect of kappa receptor ligands on dopamine release in the nucleus accumbens Physiol Behav 92 2007 167 171
37. J.J. Macintosh Stimulus control: attentional factors W.K. Honig, J.E.R. Staddon, Handbook of operant behavior 1977 Prentice-Hall Englewood Cliffs, NJ 162 241
38. I.M. Maisonneuve, S. Archer, and S.D. Glick U50,488, a kappa opioid receptor agonist, attenuates cocaine-induced increases in extracellular dopamine in the nucleus accumbens of rats Neurosci Lett 181 1994 57 60
39. W.J. McBride, and T.K. Li Animal models of alcoholism: neurobiology of high alcohol-drinking behavior in rodents Crit Rev Neurobiol 12 1998 339 369
40. W.J. McBride, J.M. Murphy, and S. Ikemoto Localization of brain reinforcement mechanisms: intracranial self-administration and intracranial place-conditioning studies Behav Brain Res 101 1999 129 152
41. L.D. Middaugh, and A.L. Bandy Naltrexone effects on ethanol consumption and response to ethanol conditioned cues in C57BL/6 mice Psychopharmacology (Berl) 151 2000 321 327
42. L.D. Middaugh, B.M. Kelley, E.R. Cuison Jr., and C.H. Groseclose Naltrexone effects on ethanol reward and discrimination in C57BL/6 mice Alcohol Clin Exp Res 23 1999 456 464
43. L.D. Middaugh, A.M. Lee, and A.L. Bandy Ethanol reinforcement in nondeprived mice: effects of abstinence and naltrexone Alcohol Clin Exp Res 24 2000 1172 1179
44. L.D. Middaugh, K.K. Szumlinski, Y. Van Patten, A.L. Marlowe, and P.W. Kalivas Chronic ethanol consumption by C57BL/6 mice promotes tolerance to its interoceptive cues and increases extracellular dopamine, an effect blocked by naltrexone Alcohol Clin Exp Res 27 2003 1892 1900
45. R.F. Mucha, and A. Herz Motivational properties of kappa and mu opioid receptor agonists studied with place and taste preference conditioning Psychopharmacology (Berl) 86 1985 274 280
46. J.M. Murphy, R.B. Stewart, R.L. Bell, N.E. Badia-Elder, L.G. Carr, and W.J. McBride Phenotypic and genotypic characterization of the Indiana University rat lines selectively bred for high and low alcohol preference Behav Genet 32 2002 363 388
47. K.A. Nealey, A.W. Smith, S.M. Davis, D.G. Smith, and B.M. Walker kappa-opioid receptors are implicated in the increased potency of intra-accumbens nalmefene in ethanol-dependent rats Neuropharmacology 61 2011 35 42
48. S.S. O'Malley, A.J. Jaffe, G. Chang, R.S. Schottenfeld, R.E. Meyer, and B. Rounsaville Naltrexone and coping skills therapy for alcohol dependence. A controlled study Arch Gen Psychiatry 49 1992 881 887
49. D.H. Overstreet, A.B. Kampov-Polevoy, A.H. Rezvani, C. Braun, R.T. Bartus, and F.T. Crews Suppression of alcohol intake by chronic naloxone treatment in P rats: tolerance development and elevation of opiate receptor binding Alcohol Clin Exp Res 23 1999 1761 1771
50. B. Przewlocka, J. Turchan, W. Lason, and R. Prezewlocki Ethanol withdrawal enhances prodynorphin system activity in the rat nucleus accumbens Neuroscience Letters 238 1997 13 16
51. Z.A. Rodd, R.L. Bell, H.J. Sable, J.M. Murphy, and W.J. McBride Recent advances in animal models of alcohol craving and relapse Pharmacol Biochem Behav 79 2004 439 450
52. Z.A. Rodd, D.L. McKinzie, R.L. Bell, V.K. McQueen, J.M. Murphy, and D.D. Schoepp The metabotropic glutamate 2/3 receptor agonist LY404039 reduces alcohol-seeking but not alcohol self-administration in alcohol-preferring (P) rats Behav Brain Res 171 2006 207 215
53. Z.A. Rodd-Henricks, R.L. Bell, K.A. Kuc, J.M. Murphy, W.J. McBride, and L. Lumeng Effects of ethanol exposure on subsequent acquisition and extinction of ethanol self-administration and expression of alcohol-seeking behavior in adult alcohol-preferring (P) rats: I. Periadolescent exposure Alcohol Clin Exp Res 26 2002 1632 1641
54. Z.A. Rodd-Henricks, R.L. Bell, K.A. Kuc, J.M. Murphy, W.J. McBride, and L. Lumeng Effects of ethanol exposure on subsequent acquisition and extinction of ethanol self-administration and expression of alcohol-seeking behavior in adult alcohol-preferring (P) rats: II. Adult exposure Alcohol Clin Exp Res 26 2002 1642 1652
55. H.J. Sable, R.L. Bell, Z.A. Rodd, and W.J. McBride Effects of naltrexone on the acquisition of alcohol intake in male and female periadolescent and adult alcohol-preferring (P) rats Int J Adolesc Med Health 18 2006 139 149
56. A. Sfikakis, Z. Papadopoulou-Daifotis, M. Sfikaki, and J. Messari Monoaminergic dysregulation on diestrus-2 and estrus through high emotional reactivity Pharmacol Biochem Behav 60 1998 285 291
57. T.S. Shippenberg, A. Herz, R. Spanagel, R. Bals-Kubik, and C. Stein Conditioning of opioid reinforcement: neuroanatomical and neurochemical substrates Ann N Y Acad Sci 654 1992 347 356
58. T.S. Shippenberg, A. Zapata, and V.I. Chefer Dynorphin and the pathophysiology of drug addiction Pharmacol Ther 116 2007 306 321
59. J.D. Sinclair Drugs to decrease alcohol drinking Ann Med 22 1990 357 362
60. R. Sinha The role of stress in addiction relapse Curr Psychiatry Rep 9 2007 388 395
61. R. Spanagel, and F. Weiss The dopamine hypothesis of reward: past and current status Trends Neurosci 22 1999 521 527
62. R. Spanagel, A. Herz, and T.S. Shippenberg The effects of opioid peptides on dopamine release in the nucleus accumbens: an in vivo microdialysis study J Neurochem 55 1990 1734 1740
63. R. Spanagel, A. Herz, and T.S. Shippenberg Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway Proc Natl Acad Sci U S A 89 1992 2046 2050
64. R. Spanagel, O.F. Almeida, C. Bartl, and T.S. Shippenberg Endogenous kappa-opioid systems in opiate withdrawal: role in aversion and accompanying changes in mesolimbic dopamine release Psychopharmacology (Berl) 115 1994 121 127
65. A.L. Svingos, C. Chavkin, E.E. Colago, and V.M. Pickel Major coexpression of kappa-opioid receptors and the dopamine transporter in nucleus accumbens axonal profiles Synapse 42 2001 185 192
66. J.B. Thomas, R.N. Atkinson, R.B. Rothman, S.E. Fix, S.W. Mascarella, and N.A. Vinson Identification of the first trans-(3R,4R)- dimethyl-4-(3- hydroxyphenyl)piperidine derivative to possess highly potent and selective opioid kappa receptor antagonist activity J Med Chem 44 2001 2687 2690
67. M.S. Todtenkopf, J.F. Marcus, P.S. Portoghese, and W.A. Carlezon Jr. Effects of kappa-opioid receptor ligands on intracranial self-stimulation in rats Psychopharmacology (Berl) 172 2004 463 470
68. J.R. Volpicelli, A.I. Alterman, M. Hayashida, and C.P. O'Brien Naltrexone in the treatment of alcohol dependence Arch Gen Psychiatry 49 1992 876 880
69. B.M. Walker, and G.F. Koob Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence Neuropsychopharmacology 33 2008 643 652
70. B.M. Walker, E.P. Zorrilla, and G.F. Koob Systemic kappa-opioid receptor antagonism by nor-binaltorphimine reduces dependence-induced excessive alcohol self-administration in rats Addict Biol 16 2011 116 119
71. S. Wee, and G.F. Koob The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuse Psychopharmacology (Berl) 210 2010 121 135
72. K.L. Williams, and J.H. Woods Oral ethanol-reinforced responding in rhesus monkeys: effects of opioid antagonists selective for the mu-, kappa-, or delta-receptor Alcohol Clin Exp Res 22 1998 1634 1639